Neoadjuvant therapy for breast cancer

L. Mangone, P. Mancuso, G. Tagliabue, R.A. Filiberti, G. Carrozzi, S. Iacovacci, W. Mazzucco, R. Tumino, P. Minicozzi, M. Sant, P. Giorgi Rossi

Research output: Contribution to journalArticlepeer-review


Objective: To evaluate the frequency of neoadjuvant therapy (NT) in women with stage I–III breast cancer in Italy and whether it is influenced by biological characteristics, screening history, and geographic area. Methods: Data from the High Resolution Study conducted in 7 Italian cancer registries were used; they are a representative sample of incident cancers in the study period (2009–2013). Included were 3546 women aged
Original languageEnglish
Pages (from-to)488-493
Number of pages6
Issue number6
Publication statusPublished - Dec 1 2019


  • Breast cancer
  • multidisciplinary
  • neoadjuvant therapy
  • adult
  • aged
  • Article
  • breast cancer
  • cancer chemotherapy
  • cancer grading
  • cancer hormone therapy
  • cancer incidence
  • cancer registry
  • cancer screening
  • cancer staging
  • cancer surgery
  • female
  • geography
  • human
  • human epidermal growth factor receptor 2 positive breast cancer
  • Italy
  • luminal A breast cancer
  • luminal B breast cancer
  • major clinical study
  • medical history
  • molecularly targeted therapy
  • partial mastectomy
  • triple negative breast cancer
  • breast tumor
  • mammography
  • middle aged
  • multimodality cancer therapy
  • odds ratio
  • treatment outcome
  • very elderly
  • tumor marker
  • Adult
  • Aged
  • Aged, 80 and over
  • Biomarkers, Tumor
  • Breast Neoplasms
  • Combined Modality Therapy
  • Female
  • Humans
  • Mammography
  • Middle Aged
  • Neoadjuvant Therapy
  • Neoplasm Staging
  • Odds Ratio
  • Treatment Outcome


Dive into the research topics of 'Neoadjuvant therapy for breast cancer'. Together they form a unique fingerprint.

Cite this